PTO Form 1478 (Rev 6/2005) |
OMB No. 0651-0009 (Exp xx/xx/xxxx) |
Trademark/Service Mark Application, Principal Register
Serial Number: 78964991
Filing Date: 08/31/2006
The table below presents the data as entered.
Input Field
|
Entered
|
MARK SECTION |
MARK |
PRASCEND |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
PRASCEND |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font, style, size, or color. |
OWNER SECTION |
NAME |
Eli Lilly and Company |
STREET |
Lilly Corporate Center |
CITY |
Indianapolis |
STATE |
Indiana |
ZIP/POSTAL CODE |
46285 |
COUNTRY |
United States |
PHONE |
317 651 1346 |
FAX |
317 276 1919 |
EMAIL |
XXXX |
AUTHORIZED EMAIL COMMUNICATION |
Yes |
LEGAL ENTITY SECTION |
TYPE |
CORPORATION |
STATE/COUNTRY OF INCORPORATION |
Indiana |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
DESCRIPTION |
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and
disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine diseases and disorders, gastrointestinal diseases and disorders,
hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders,
neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction,
urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; pharmaceutical preparations for the prevention of diabetes; antipsychotic agents; and
antidepressants. |
FILING BASIS |
Section 1(b) |
ADDITIONAL STATEMENTS SECTION |
MISCELLANEOUS STATEMENT |
The mark is a coined, non-dictionary word with no English translation. |
SIGNATURE SECTION |
SIGNATURE |
/blongbottom/ |
SIGNATORY NAME |
Bruce W. Longbottom |
SIGNATORY DATE |
08/31/2006 |
SIGNATORY POSITION |
Associate General Counsel |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
NUMBER OF CLASSES PAID |
1 |
SUBTOTAL AMOUNT |
325 |
TOTAL AMOUNT |
325 |
PAYMENT METHOD |
DA |
ATTORNEY |
NAME |
Bruce W. Longbottom |
FIRM NAME |
Eli Lilly and Company |
STREET |
Lilly Corporate Center |
CITY |
Indianapolis |
STATE |
Indiana |
ZIP/POSTAL CODE |
46285 |
COUNTRY |
United States |
PHONE |
317 651 1346 |
FAX |
317 276 1919 |
EMAIL |
trademarks@lilly.com |
AUTHORIZED EMAIL COMMUNICATION |
Yes |
OTHER APPOINTED ATTORNEY(S) |
Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch |
CORRESPONDENCE SECTION |
NAME |
Bruce W. Longbottom |
FIRM NAME |
Eli Lilly and Company |
STREET |
Lilly Corporate Center |
CITY |
Indianapolis |
STATE |
Indiana |
ZIP/POSTAL CODE |
46285 |
COUNTRY |
United States |
PHONE |
317 651 1346 |
FAX |
317 276 1919 |
EMAIL |
trademarks@lilly.com |
AUTHORIZED EMAIL COMMUNICATION |
Yes |
FILING INFORMATION |
SUBMIT DATE |
Thu Aug 31 14:06:36 EDT 2006 |
TEAS STAMP |
USPTO/BAS-XXXXXXX-2006083
1140636585339-78964991-20
0aa50b232818decf29891cae8
dd811a-DA-1893-2006083111
2732823624 |
PTO Form 1478 (Rev 6/2005) |
OMB No. 0651-0009 (Exp xx/xx/xxxx) |
Trademark/Service Mark Application, Principal Register
Serial Number: 78964991
Filing Date: 08/31/2006
To the Commissioner for Trademarks:
MARK: (Standard Characters, see
mark)
The mark consists of standard characters, without claim to any particular font, style, size, or color.
The literal element of the mark consists of PRASCEND.
The applicant, Eli Lilly and Company, a corporation of Indiana, residing at Lilly Corporate Center, Indianapolis, Indiana, United States, 46285, requests registration of the trademark/service mark
identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended.
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or
services. (15 U.S.C. Section 1051(b)).
International Class 005: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal
diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine diseases and disorders,
gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders,
neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases
and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; pharmaceutical preparations for the prevention of diabetes;
antipsychotic agents; and antidepressants.
The mark is a coined, non-dictionary word with no English translation.
The applicant hereby appoints Bruce W. Longbottom and Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, United
States, 46285 to submit this application on behalf of the applicant.
The USPTO is authorized to communicate with the applicant or its representative at the following email address: trademarks@lilly.com.
A fee payment in the amount of $325 will be submitted with the application, representing payment for 1 class(es).
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the
applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes
applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either
in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake,
or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
Signature: /blongbottom/ Date: 08/31/2006
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Associate General Counsel
Mailing Address:
Bruce W. Longbottom
Lilly Corporate Center
Indianapolis, Indiana 46285
RAM Sale Number: 1893
RAM Accounting Date: 08/31/2006
Serial Number: 78964991
Internet Transmission Date: Thu Aug 31 14:06:36 EDT 2006
TEAS Stamp: USPTO/BAS-XXXXXXX-20060831140636585339-7
8964991-200aa50b232818decf29891cae8dd811
a-DA-1893-20060831112732823624